Preview

Современная ревматология

Расширенный поиск

Костно-мышечные потери у больных анкилозирующим спондилитом

https://doi.org/10.14412/1996-7012-2019-4-104-109

Полный текст:

Аннотация

Анкилозирующий спондилит (АС) – одно из наиболее распространенных аутовоспалительных заболеваний, приводящих к ранней утрате трудоспособности больных и высокому уровню преждевременной смертности. Наряду со снижением минеральной плотности кости для больных АС характерно и уменьшение мышечной массы – саркопения. Костно-мышечные потери, обусловленные хроническим иммунным воспалением и ограничением физического функционирования, значительно ухудшают прогноз и обусловливают высокий риск падений и переломов у больных АС.

В обзоре рассмотрены патогенетические механизмы взаимосвязи АС и саркопении и основные подходы к лечению дегенеративных изменений мышечной ткани у больных АС.

Об авторах

Т. А. Раскина
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России
Россия

Татьяна Алексеевна Раскина

650056, Кемерово, ул. Ворошилова, 22А



И. И. Григорьева
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России
Россия
650056, Кемерово, ул. Ворошилова, 22А


О. С. Малышенко
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России
Россия
650056, Кемерово, ул. Ворошилова, 22А


Литература

1. Шостак НА, Мурадянц АА, Кондрашов АА. Саркопения и перекрестные синдромы – значение в клинической практике. Клиницист. 2016;10(3):10-4.

2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010 Jul; 39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.

3. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.

4. Roubenoff R. Sarcopenia effects on body composition and function. J Gerontol A Biol Sci Med Sci. 2003 Nov;58(11):1012-7.

5. Ling CH, Taekema D, de Craen AJ, et al. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ. 2010 Mar 23;182(5):429-35. doi: 10.1503/cmaj.091278. Epub 2010 Feb 8.

6. Лесняк ОМ. Остеопороз: руководство для врачей. Москва: ГЭОТАР-Медиа; 2016. 464 с.

7. Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, Halil M. Sarcopenia in critically ill patients. J Anesth. 2016 Oct;30(5):884-90. doi: 10.1007/s00540-016-2211-4. Epub 2016 Jul 4.

8. Peterson SJ, Braunschweig CA. Prevalence of Sarcopenia and Associated Outcomes in the Clinical Setting. Nutr Clin Pract. 2016 Feb; 31(1):40-8. doi: 10.1177/0884533615622537. Epub 2015 Dec 24.

9. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013 Oct 16;310(15):1591-600.

10. Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer. 2016 Apr; 57:58-67. doi: 10.1016/j.ejca.2015.12.030. Epub 2016 Feb 13.

11. Collamati A, Marzetti E, Calvani R, et al. Sarcopenia in heart failure: mechanisms and therapeutic strategies. J Geriatr Cardiol. 2016 Jul;13(7):615-24. doi: 10.11909/j.issn.1671-5411.2016.07.004.

12. Hirai K, Ookawara S, Morishita Y. Sarcopenia and Physical Inactivity in Patients With Chronic Kidney Disease. Nephrourol Mon. 2016 Apr 26;8(3):e37443. doi: 10.5812/numonthly.37443. eCollection 2016 May.

13. Насонов ЕЛ, редактор. Ревматология. Российские клинические рекомендации. Москва: ГЭОТАР-Медиа; 2017. 456 с.

14. Эрдес ШФ, Бадокин ВВ, Бочкова АГ и др. О терминологии спондилоартритов. Научно-практическая ревматология. 2015;53(6):657–60. doi: 10.14412/1995-4484-2015-657-660.

15. Barone M, Viggiani MT, Anelli MG, et al. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. J Clin Med. 2018 Dec 1;7(12). pii: E504. doi: 10.3390/jcm7120504.

16. Fitzgerald G, O'Shea F. High Prevalence of Sarcopenia in Axial Spondyloarthropathy Cohort [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/highprevalence-of-sarcopenia-in-axial-spondyloarthropathy-cohort/

17. El Maghraoui A, Ebo'o FB, Sadni S, et al. Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis? BMC Musculoskelet Disord. 2016 Jul 11;17:268. doi: 10.1186/s12891-016-1155-z.

18. Aguiar R, Sequeira J, Meirinhos T, et al. SARCOSPA – Sarcopenia in spondyloarthritis patients. Acta Reumatol Port. 2014 Oct-Dec;39(4):322-6.

19. Korhonen MT, Cristea A, Alen M, at al. Aging, muscle fiber type, and contractile function in sprint-trained athletes. J Appl Physiol (1985). 2006 Sep;101(3):906-17. Epub 2006 May 11.

20. Rоren Norden K, Dagfinrud H, LΔvstad A, Raastad T. Reduced Appendicular Lean Body Mass, Muscle Strength, and Size of Type II Muscle Fibers in Patients with Spondyloarthritis versus Healthy Controls: A Cross-Sectional Study. ScientificWorldJournal. 2016;2016:6507692. Epub 2016 Sep 8.

21. Torii M, Hashimoto M, Hanai A, et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod Rheumatol. 2019 Jul;29(4):589-595. doi: 10.1080/14397595.2018.1510565. Epub 2018 Sep 11.

22. Plasqui G, Boonen A, Geusens P, et al. Physical activity and body composition in patients with ankylosing spondylitis. Arthritis Care Res (Hoboken). 2012 Jan;64(1):101-7. doi: 10.1002/acr.20566.

23. Park CH, Do JG, Lee YT, et al. Sarcopenic obesity associated with highsensitivity C-reactive protein in age and sex comparison: a two-center study in South Korea. BMJ Open. 2018 Sep 19;8(9):e021232. doi: 10.1136/bmjopen-2017-021232.

24. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002 May;57(5):M326-32.

25. Schaap LA, Pluijm SM, Deeg DJ, et al. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006 Jun;119(6):526.e9-17.

26. Engvall IL, Elkan AC, Tengstrand B, et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol. 2008 Sep-Oct;37(5):321-8. doi: 10.1080/03009740802055984.

27. Ceyhan Dogan S, Hizmetli S, Hayta E, et al. Sarcopenia in women with rheumatoid arthritis. Eur J Rheumatol. 2015 Jun;2(2): 57-61. Epub 2015 Mar 31.

28. Giles JT, Ling SM, Ferrucci L, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008 Jun 15; 59(6):807-15. doi: 10.1002/art.23719.

29. Dao HH, Do QT, Sakamoto J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology (Oxford). 2011 Jul;50(7): 1250-8. doi: 10.1093/rheumatology/ker004. Epub 2011 Feb 3.

30. Vodnizza SE, Visman IM, Denderen CJ, et al. FRI0461 Muscle wasting in male TNF-α blocker naмve ankylosing spondylitis patients: a comparison of gender differences in body composition with dual-energy X-ray absorptiometry. Annals of the Rheumatic Diseases. 2017;76:661.

31. Gupta S, Dhillon RJS, Hasni S. Sarcopenia: A Rheumatic Disease? Rheum Dis Clin North Am. 2018 Aug;44(3):393-404. doi: 10.1016/j.rdc.2018.03.001. Epub 2018 Jun 12.

32. Taaffe DR, Duret C, Wheeler S, Marcus R. Once-Weekly Resistance Exercise Improves Muscle Strength and Neuromuscular Performance in Older Adults. J Am Geriatr Soc. 1999 Oct;47(10):1208-14.

33. Rondanelli M, Klersy C, Terracol G, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr. 2016 Mar;103(3):830-40. doi: 10.3945/ajcn.115.113357. Epub 2016 Feb 10.

34. Paddon-Jones D, Sheffield-Moore M, Katsanos CS, et al. Differential stimulation of muscle protein synthesis in elderly humans following isocaloric ingestion of amino acids or whey protein. Exp Gerontol. 2006 Feb; 41(2):215-9. Epub 2005 Nov 23. doi: 10.1016/j.exger.2005.10.006.

35. Dawson-Hughes B. Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nutr. 2008 Aug;88(2):537S540S. doi: 10.1093/ajcn/88.2.537S.

36. Dhillon RJ, Hasni S. Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2017 Feb;33(1):17-26. doi: 10.1016/j.cger.2016.08.002.

37. Cruz-Jentoft AJ. Sarcopenia: what should a pharmacist know? Farm Hosp. 2017 Jul 1; 41(4):543-549. doi: 10.7399/fh.2017.41.4.10802.

38. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115. doi:10.1034/j.1601-5215.2002.51018.x.

39. Giovannini S, Marzetti E, Borst SE, Leeuwenburgh C. Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech Ageing Dev. 2008 Oct;129(10):593-601. doi: 10.1016/j.mad.2008.08.001. Epub 2008 Aug 13.

40. Wittert GA, Chapman IM, Haren MT, et al. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):618-25.

41. Van Geel TA, Geusens PP, Winkens B, et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol. 2009 Apr;160(4):681-7. doi: 10.1530/EJE-08-0702. Epub 2009 Jan 27.

42. Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ. 2008 Jun;32(2):120-6. doi: 10.1152/advan.90111.2008.

43. Kaji H. Interaction between Muscle and Bone. J Bone Metab. 2014 Feb;21(1):29-40. doi: 10.11005/jbm.2014.21.1.29. Epub 2014 Feb 28.

44. Barros M, Saad C, Takayama L, et al. THU0266 Sarcopenia reversal in ankylosing spondylitis (AS) under anti-tnf therapy: A 24-month longitudinal analysis. Ann Rheum Dis. 2013;71:244-5.

45. Orsatti FL, Nahas EA, Nahas-Neto J, et al. Low appendicular muscle mass is correlated with femoral neck bone mineral density loss in postmenopausal women. BMC Musculoskelet Disord. 2011 Oct 7;12:225. doi: 10.1186/1471-2474-12-225.

46. Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int. 2013 Apr;13(2):413-20. doi: 10.1111/j.1447-0594.2012.00918.x. Epub 2012 Jul 23.

47. Walsh MC, Hunter GR, Livingstone MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int. 2006 Jan;17(1):61-7. Epub 2005 Jul 2. doi: 10.1007/s00198-005-1900-x.


Для цитирования:


Раскина Т.А., Григорьева И.И., Малышенко О.С. Костно-мышечные потери у больных анкилозирующим спондилитом. Современная ревматология. 2019;13(4):104-109. https://doi.org/10.14412/1996-7012-2019-4-104-109

For citation:


Raskina T.A., Grigorieva I.I., Malyshenko O.S. Musculoskeletal losses in patients with ankylosing spondylitis. Modern Rheumatology Journal. 2019;13(4):104-109. (In Russ.) https://doi.org/10.14412/1996-7012-2019-4-104-109

Просмотров: 20


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)